Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Mr. Kevin J. BuehlerIndependent Chairman | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 49,14k | 74,63% |
| 2026-05-20 | Dr. Stanley R. FrankelIndependent Director | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 40,48k | 107,81% |
| 2026-05-20 | Ms. Melinda BrownIndependent Director | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 44,35k | 89,95% |
| 2026-05-20 | Ms. Shari Lisa PireIndependent Director | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 35,03k | 149,70% |
| 2026-05-20 | Mr. Geno J. GermanoIndependent Director | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 44,88k | 87,93% |
| 2026-02-17 | Mr. Dario ScimecaGeneral Counsel & Secretary | -4,93k | 18,91k | Derivative Exercise and Sale | 3,84 | 56,46k | - |
| 2026-02-17 | Mr. Michael AmorosoPresident, CEO & Director | 47,24k | 0,00 | Derivative Exercise and Retained Stock | - | 243,39k | 24,08% |
| 2026-02-17 | Mr. Michael AmorosoPresident, CEO & Director | -20,56k | 78,95k | Derivative Exercise and Sale | 3,84 | 243,39k | - |
| 2026-02-17 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | 11,74k | 0,00 | Derivative Exercise and Retained Stock | - | 129,86k | 9,94% |
| 2026-02-17 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | -4,93k | 18,91k | Derivative Exercise and Sale | 3,84 | 129,86k | - |
| 2026-02-17 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 19,44k | 0,00 | Derivative Exercise and Retained Stock | - | 125,88k | 18,26% |
| 2026-02-17 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -8,15k | 31,29k | Derivative Exercise and Sale | 3,84 | 125,88k | - |
| 2026-02-17 | Mr. Dario ScimecaGeneral Counsel & Secretary | 11,74k | 0,00 | Derivative Exercise and Retained Stock | - | 56,46k | 26,26% |
| 2026-01-20 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 29,15k | 0,00 | Derivative Exercise and Retained Stock | - | 106,45k | 37,71% |
| 2026-01-20 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -15,21k | 61,31k | Derivative Exercise and Sale | 4,03 | 106,45k | - |
| 2026-01-20 | Mr. Dario ScimecaGeneral Counsel & Secretary | 16,46k | 0,00 | Derivative Exercise and Retained Stock | - | 44,72k | 58,24% |
| 2026-01-20 | Mr. Dario ScimecaGeneral Counsel & Secretary | -8,85k | 35,68k | Derivative Exercise and Sale | 4,03 | 44,72k | - |
| 2026-01-20 | Mr. Michael AmorosoPresident, CEO & Director | 80,58k | 0,00 | Derivative Exercise and Retained Stock | - | 196,15k | 69,72% |
| 2026-01-20 | Mr. Michael AmorosoPresident, CEO & Director | -34,80k | 145,11k | Derivative Exercise and Sale | 4,17 | 196,15k | - |
| 2026-01-20 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | 18,97k | 0,00 | Derivative Exercise and Retained Stock | - | 118,12k | 19,13% |
| 2026-01-21 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | -10,20k | 41,11k | Derivative Exercise and Sale | 4,03 | 118,12k | - |
| 2025-12-16 | Mr. Geno J. GermanoIndependent Director | 3,00k | 14,16k | Kauf | 4,72 | 23,88k | 14,37% |
| 2025-12-15 | Ms. Melinda BrownIndependent Director | 1,38k | 6,86k | Kauf | 4,97 | 23,35k | 6,29% |
| 2025-12-16 | Dr. Stanley R. FrankelIndependent Director | 2,70k | 12,69k | Kauf | 4,70 | 19,48k | 16,09% |
| 2025-11-02 | Mr. Dario ScimecaGeneral Counsel & Secretary | 1,17k | 0,00 | Derivative Exercise and Retained Stock | - | 28,26k | 4,32% |
| 2025-11-02 | Mr. Dario ScimecaGeneral Counsel & Secretary | -665,00 | 4,32k | Derivative Exercise and Sale | 6,49 | 28,26k | - |
| 2025-11-02 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 2,30k | 0,00 | Derivative Exercise and Retained Stock | - | 77,30k | 3,07% |
| 2025-11-02 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -1,30k | 8,46k | Derivative Exercise and Sale | 6,49 | 77,30k | - |
| 2025-11-02 | Mr. Michael AmorosoPresident, CEO & Director | 6,04k | 0,00 | Derivative Exercise and Retained Stock | - | 115,58k | 5,51% |
| 2025-11-02 | Mr. Michael AmorosoPresident, CEO & Director | -3,41k | 22,12k | Derivative Exercise and Sale | 6,49 | 115,58k | - |
| 2025-09-26 | Dr. Stanley R. FrankelIndependent Director | 2,70k | 13,42k | Kauf | 4,97 | 16,78k | 19,18% |
| 2025-09-22 | Ms. Melinda BrownIndependent Director | 1,40k | 6,85k | Kauf | 4,89 | 21,97k | 6,81% |
| 2025-07-03 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -14,83k | 63,16k | Automatic Disposition | 4,26 | 73,49k | -16,79% |
| 2025-06-25 | Ms. Melinda BrownIndependent Director | 1,68k | 6,96k | Kauf | 4,14 | 20,57k | 8,91% |
| 2025-06-25 | Mr. Kevin J. BuehlerIndependent Chairman | 5,08k | 21,12k | Kauf | 4,16 | 28,14k | 22,01% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
